FDA Expands Label of Oral HIV Drug to Newborns
28/08/2026
The FDA expanded the approval of dolutegravir tablets for oral suspension (Tivicay PD) to include newborns with HIV infections younger
La proporción de mujeres que nunca se han sometido a pruebas de cáncer cervical ha aumentado más del 5% por…
Read more →
The FDA expanded the approval of dolutegravir tablets for oral suspension (Tivicay PD) to include newborns with HIV infections younger
Resumen de lo sucedido: Citing reporting by ProPublica, eight Democratic U.S. senators have criticized the Trump administration’s demands to access
AMHERST, Mass. — For the last 30 years, whenever pediatrician John Snyder, MD, wanted to find the most up-to-date research
Introducción The CDC on Tuesday warned doctors about the risk for severe arboviral neuroinvasive disease in patients on B cell-depleting
Introducción Switching to a weekly oral investigational regimen of islatravir and lenacapavir (Sunlenca) was just as effective as daily oral